Common side effects include nausea, vomiting and constipation, particularly during dose escalation
Safety concerns : Important risks associated with GLP-1 receptor agonists include pancreatitis, gallbladder disease, dehydration leading to acute kidney injury, hypoglycaemia (when used with insulin or sulfonylureas), and potential worsening of diabetic retinopathy with rapid glycaemic improvement
These are frequent enough that someone on the medication may well have them
Payment flexibility supports various budgets through HSA and FSA account eligibility
In a highly litigious atmosphere, with several major compounding players opting not to test the limits of whats legally permissible, there will indeed be a significant subset of patients who struggle to find accessible, affordable meds
Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA-based weight-loss therapies